US 8211935
Heterocyclic derivatives for modulation of calcium channels
granted A61KA61K31/343A61K31/381
Quick answer
US patent 8211935 (Heterocyclic derivatives for modulation of calcium channels) held by Vertex Pharmaceuticals Incorporated expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Jul 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/343, A61K31/381, A61K31/404, A61K31/405